SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-20-245314
Filing Date
2020-09-14
Accepted
2020-09-14 17:24:59
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d11782dsc14d9.htm SC 14D9 672876
2 EX-99.(E)(2) d11782dex99e2.htm EX-99.(E)(2) 43581
3 GRAPHIC g11782g24p64.jpg GRAPHIC 20830
  Complete submission text file 0001193125-20-245314.txt   746876
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filed by) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Subject) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-90051 | Film No.: 201174005
SIC: 2834 Pharmaceutical Preparations